These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26878133)

  • 1. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
    Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
    Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
    Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
    Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling of primary high-grade soft tissue sarcomas.
    Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
    Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of altered MicroRNA expression patterns in synovial sarcoma.
    Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
    Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a blood-borne miRNA signature of synovial sarcoma.
    Fricke A; Ullrich PV; Heinz J; Pfeifer D; Scholber J; Herget GW; Hauschild O; Bronsert P; Stark GB; Bannasch H; Eisenhardt SU; Braig D
    Mol Cancer; 2015 Aug; 14():151. PubMed ID: 26250552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
    Tanriverdi O; Yildiz A
    J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
    Italiano A; Di Mauro I; Rapp J; Pierron G; Auger N; Alberti L; Chibon F; Escande F; Voegeli AC; Ghnassia JP; Keslair F; Laé M; Ranchère-Vince D; Terrier P; Baffert S; Coindre JM; Pedeutour F
    Lancet Oncol; 2016 Apr; 17(4):532-538. PubMed ID: 26970672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
    Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
    Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
    Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
    Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.
    Hill DA; O'Sullivan MJ; Zhu X; Vollmer RT; Humphrey PA; Dehner LP; Pfeifer JD
    Am J Surg Pathol; 2002 Aug; 26(8):965-77. PubMed ID: 12170083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipomatous tumors.
    Weiss SW
    Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
    Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
    Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
    Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
    Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
    Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.